Combination product of a 1,4-benzothiepine 1,1-dioxide...

Details Combination product of a 1,4-benzothiepine 1,1-dioxide... Combination product of a 1,4-benzothiepine 1,1-dioxide...

2007-02-20

2007-02-20

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S019300, C514S023000, C530S330000, C530S331000, C536S017200

Reexamination Certificate

active

10699967

ABSTRACT:
The present invention is directed to a 1,4-benzothiepine 1,1-dioxide compound of formula Iin which the radicals have the meanings defined herein, or a pharmaceutically acceptable salt or physiologically functional derivative thereof, with at least one other active ingredient, or a pharmaceutically acceptable salt or physiologically functional derivative thereof. The invention is also directed to the use of the combination product, pharmaceutical composition comprising the combination product and method for preparing the pharmaceutical composition.

REFERENCES:
patent: 5190923 (1993-03-01), Vincent et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch
patent: 6380230 (2002-04-01), Brodin et al.
patent: 6387944 (2002-05-01), Frick et al.
patent: 6441022 (2002-08-01), Frick et al.
patent: 6498156 (2002-12-01), Glombik
patent: 2003/0191174 (2003-10-01), Ikuta et al.
patent: WO 97/26265 (1997-07-01), None
patent: WO 97/41097 (1997-11-01), None
patent: WO 98/08871 (1998-03-01), None
patent: WO 99/03861 (1999-01-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/85695 (2001-11-01), None
patent: WO 01/91752 (2001-12-01), None
AHFS Drug Information, 1994, pp. 1096-1103.
Castaner, R.M. et al Drugs of the Future, 2000, 25(7), 679-685.
Castaner, R. M. et al, Drugs of the Future, 2000, 25(7), 679-685.
Asakawa, A., et al., Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice, Hormone and Metabolic Research, 2001, vol. 33(9), pp. 554-558.
Lee Daniel W., et al., Leptin Agonists As A Potential Approach To The Treatment Of Obesity, Drugs Of The Future, (2001), vol. 26, No. 9, pp. 873-881.
Salvador Javier, et al., Perspectives in the Therapeutic Use of Leptin, Expert Opin. Pharmacother. (2001), vol. 2(10), pp. 1615-1622.
Zunft, H. et al., Carob Pulp Preparation for Treatment of Hypercholesterolemia, Advances in Therapy, 2001, vol. 18(5), pp. 230-236.

Affiliated with

Also associated with

Rating

Combination product of a 1,4-benzothiepine 1,1-dioxide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination product of a 1,4-benzothiepine 1,1-dioxide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination product of a 1,4-benzothiepine 1,1-dioxide... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3883227